Skip to main content

Table 1 Protocol schemes

From: Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial

 

Protocol 1 (n = 4)

Protocol 2 (n = 6)

Rituximab

1000 mg on days −14 and −7, followed by treatment every 6 months

375 mg/m2 on day 1 every 3 weeks

Cisplatin

70 mg/m2 on day 1 every 3 weeks

70 mg/m2 on day 1 every 3 weeks

Gemcitabine

1000 mg/m2 on days 1 and 8 every 3 weeks

1000 mg/m2 on days 1 and 8 every 3 weeks